Sr Director - U.S. Ethics & Compliance Advisor at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Candidates must possess a bachelor's degree with 14 years of compliance experience or a master's degree with 12 years of relevant experience. Experience in the biotech or pharmaceutical industry is required. Proven ability to build strong relationships with stakeholders and a problem-solving mindset are essential. Experience in practices related to interactions between commercial, medical affairs, and market access is necessary. People leadership experience is also required.

Responsibilities

The Sr Director will serve as the primary ethics and compliance advisor for Gilead's US Commercial operations, partnering with Legal, Commercial, Medical, and Clinical Development leaders to integrate the compliance program. They will advise on and support the operationalization of compliance processes, develop and deliver training, and assess healthcare compliance risks, developing mitigation controls. Responsibilities include partnering with Privacy and Data Ethics teams, supporting incident response, and facilitating policy, monitoring, risk assessments, due diligence, and transparency initiatives. The role also involves staying current with ethics and compliance developments, leading and developing a team, and fostering a high-performance culture.

Skills

Ethics

Compliance

Commercial

Legal

Medical Affairs

Market Access

Stakeholder Management

Problem-Solving

Communication

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free